Edgewise Therapeutics, Inc. EWTX
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Srikripa Devarakonda | Truist Financial | 31.57 $ | 50 $ | 18.43 % | 05/12/2024 |
| Yasmeen Rahimi | Piper Sandler | 30.455 $ | 51 $ | 20.55 % | 11/10/2024 |
| Leonid Timashev | RBC Capital | 29.5 $ | 42 $ | 12.50 % | 20/09/2024 |
| Joseph Schwartz | Leerink Partners | 29.5 $ | 42 $ | 12.50 % | 19/09/2024 |
| Yasmeen Rahimi | Piper Sandler | 18.01 $ | 48 $ | 29.99 % | 01/07/2024 |